Vial
vial.com
Actively hiring
Clinical Trial Software
Clinical Trial Services (CRO)
As featured in
Claim pageClaim
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$67M
1 round on record
Latest round
$67M
Venture round · Dec 2022 · 3 yr ago
Team
201-500
employees, estimated range
Hiring now
1
+1 posted in 30 days
Backers
1
General Catalyst
The money's age
Long since its last round
46 months since the last round · and hiring
Momentum
28/100
hiring for its size, in the news
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Dec 2022 | $67M | — | mobihealthnews.com |
Backed byfrom the funds' portfolios and accelerator catalogs
General Catalyst Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Curebase is a clinical research technology company that runs decentralized and hybrid clinical trials for pharmaceutical, biotechnology and…
We improve the quality and efficiency of clinical trials, helping biopharmaceutical companies, CROs, and institutions facilitate the…
Lindus Health is an artificial intelligence native contract research organisation that runs clinical trials end to end. Founded in 2021 in…
A configurable, end-to-end clinical trial platform designed to accelerate study startup, improve data quality, and simplify trial execution.
Tired of legacy IRT software? Korio's modern RTSM platform adapts to any protocol change, cuts mid-study time & cost, and keeps clinical…
Advarra advances the way clinical research is conducted: bringing life sciences companies, CROs, research sites, investigators, and…
Overview
Vial is a contract research organisation that runs clinical trials on its own software stack for electronic data capture and site management. It argues that owning the technology cuts the cost and duration of a trial compared with legacy CROs. The company focuses on dermatology, ophthalmology and other specialty indications.
News
From Sharpie markings to reliable vial labeling in analytical development
Discover why analytical development teams are moving beyond Sharpie markings and manual labels to improve vial identification.
Read more
Report
How to improve vial labeling in compound management workflows
Improve vial labelling in compound management workflows to reduce errors and strengthen sample traceability.
Read more
Report
Vial Doses First Patient for Phase 1 Trial of Vial's IL-13 x TSLP, a Novel Bispecific Antibody
Vial's IL13 x TSLP is a half-life-extended bispecific antibody engineered for projected quarterly-to-biannual dosing Preclinical data demonstrates picomolar binding affinities for both IL-13 and TSLP, with near-complete inhibition of CCL17 secretion versu
Read more
Report
Vial is geared up to attend the 44th Annual J.P. Morgan Healthcare Conference in San Francisco
Vial is geared up to attend the 44th Annual J.P. Morgan Healthcare Conference in San Francisco.
Read more
Report
Dr. JiaDe Yu, Chair of Dermatology and Associate Professor at Virginia Commonwealth University School of Medicine, highlights how dual inhibition of IL-13 and TSLP could advance care for patients with atopic dermatitis, delivering stronger efficacy than targeting either pathway alone.
Vial is your top enrolling clinical trial site partner. With sites across the country within Dermatology clinics and our recruiting engine, we can guarantee leading recruitment.
Read more
Report
Buzzy healthtech startup Vial slashed an entire division weeks before a $67 million raise from General Catalyst. Insiders say they had no idea the layoffs were coming.
Weeks before announcing it had secured more than $60 million in fresh funding from General Catalyst, biotech startup Vial last fall quietly laid off dozens of employees.
Read more
Report
Show more news
Tech stack
Technologies named in job postings at Vial over the last 12 months, by layer, with the share of postings for each.
Technologies in use
1
Postings analysed
1
Stack modernity
85/100
Languages
SQL
Sign in to see how your skills match this stack
Sign In
Growth
Hiring Momentum
73/100
Growing
Open positions
1
1 opened / 0 closed in 30 days
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Operations
100% ▲
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Francisco
United States
HQ
Financials
Total raised
$67M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2022 | $67M | Details |